Emerging modes-of-action in drug discovery
Copyright policy ) Eric Valeur; Frank Narjes; Christian Ottmann; Alleyn T. Plowright;
Emerging modes-of-action in drug discovery
An increasing focus on complex biology to cure diseases rather than merely treat symptoms is transforming how drug discovery can be approached, and expands the arsenal of drug modalities and modes-of-actions that can be leveraged to modify diseases.
- AstraZeneca (Sweden) Sweden
- University of Duisburg-Essen Germany
- Sanofi (Germany) Germany
- Eindhoven University of Technology Netherlands
- ASTRAZENECA UK LIMITED United Kingdom
Chemie
Chemie
selected citations These citations are derived from selected sources.This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).22 popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.Top 10% influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).Average impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network.Top 10%
selected citations
Citations provided by BIP!
These citations are derived from selected sources.
This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically).
Citations provided by BIP!popularityPopularity provided by BIP!
This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network.
Popularity provided by BIP! 22
Top 10%
Average
Top 10%
bronze
